C.R. Bard Inc., a manufacturer of transvaginal mesh, has agreed to settle the second vaginal mesh implant case for an undisclosed sum. The case was set for trial this month in New Jersey.
The case alleged Bard's Avaulta Plus implant caused urinary problems and other internal problems. The case represents the second lawsuit Bard has settled since a jury in Charleston, West Virginia, ordered the device maker to pay $2 million to a woman who suffered injuries from the company's device.
Bard faces over 8,000 claims related to its Avaulta line of inserts, which may cause organ damage and painful intercourse due to the devices eroding. Bard pulled its Avaulta implants off the market last year after the FDA ordered all TVM device makers to further study rates of organ damage, infection, and painful intercourse.
Other vaginal mesh manufacturers, including Johnson & Johnson, Endo Health Solutions Inc., and Boston Scientific Corp. face similar lawsuits across the country related to TVM products.
Many of the implant cases against Bard and other manufacturers have been consolidated before U.S. District Judge Joseph Goodwin in Charleston, West Virginia, for pretrial purposes. Other cases have been filed in state courts around the country.